Patent US4569913A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4569913A Expired / Lapsed US ⏱️ 0.0 years remaining

P. obtusus pyranose-2-oxidase preparation

Assignee: Cetus Oncology Corp
•
Filing: 1984-02-24
•
Granted: 1986-02-11
•
Expires: 2004-02-24
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A substantially pure pyranose-2-oxidase preparation obtained from P. obtusus, and preferably from a high-producer strain thereof. The preparation is substantially free of glucosone-utilizing enzyme contaminants having measurable activity at a pH between about 4.4 and 7.0.

Inventors

  • 👤 Kirston E. Koths
  • 👤 Robert F. Halenbeck

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-09 20:52
CPC Classifications
C; C12; C12N; C12N9/00; C12N9/0004; C12N9/0006; Y; Y10; Y10S; Y10S435/00; Y10S435/8215; Y10S435/911

Claims Analysis

Total Claims: 7
Claim 1
Independent Claim 38 words
A substantially pure pyranose-2-oxidase preparation which is substantially free of glucosone-utilizing enzyme contaminants, including pyranosone dehydratase activity which have measurable activity at a selected pH between about 4.4 and 7.0, prepared from mycelia of a P obtusus culture.
Claim 2
Dependent Claim 38 words
A substantially pure pyranose-2-oxidase preparation which is substantially free of glucosone-utilizing enzyme contaminants, including pyranosone dehydratase activity which have measurable activity at a selected pH between about 4.4 and 7.0, prepared from mycelia of a P obtusus culture.
Claim 3
Dependent Claim 73 words
The preparation of claim 1 having pyranose-2-oxidase enzyme characteristics of a native tetrameric molecular weight of about 290,000 daltons; a native subunit molecular weight of about 69,000 daltons, a sedimentation coefficient of about 11.4, covalently bound flavin, absorption maxima at 276, 357, and 456 nm, relative activities toward glucose, sorbose, xylose and delta-gluconolactone substrates of approximately 100: 80: 48: 12, respectively, at 1% (w/v) substrate concentrations, and a pH optimum of about 5.0.
Claim 4
Dependent Claim 24 words
The preparation of claim 2, having the additional characteristics of having partially proteolyzed subunits with molecular weights of about 65,000, 34,000 and 30,000 daltons.
Claim 5
Dependent Claim 16 words
The preparation of claim 1, wherein the enzyme is purified in the presence of protease inhibitors.
Claim 6
Dependent Claim 62 words
The preparation of claim 1, wherein the P. obtusus cells from which the enzyme is isolated are from a culture grown from cells selected from a population of mutagenized cells according to their ability to produce a culture with a level of glucose-2-oxidase activity, in a broken-cell glucosone assay, which is at least two times that produced by cultures of unmutagenized cells.
Claim 7
Dependent Claim 30 words
The enzyme of claim 5, wherein the culture of selected P. obtusus cells has the characteristics of a culture of P. obtusus strain AU124, deposited at NRRL under No. 15595.

References Cited (Backward Citations)

US4246347A Cited
US4351902A Cited
US4321324A Cited
US4321323A Cited
US4423149A Cited
US4442207A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1989-02-10 1989-08-12 1990-02-11 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1993-02-10 1993-08-12 1994-02-11 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1997-02-10 1997-08-12 1998-02-11 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag